Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TVTX stock hub

Travere Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TVTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TVTX

In the news

Latest news · TVTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.5

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-69.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-40.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TVTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001438533
Company name	Travere Therapeutics, Inc.
Country	United States
Country code	US
Cusip	89422G107
Employees	497
Employees Change	112%
Employees Change Percent	29.09
Enterprise value	$4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US89422G1076
Last refreshed	2026-05-10
Market cap	$4B
Market cap category	Mid-Cap
Price	$42.6
Price currency	USD
Rev Per Employee	1,078,863.18x
Sector	Healthcare
Sic	2834
Symbol	TVTX
Website	https://travere.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.54%
EV Sales Forward	5.12x
EV/EBITDA	250.15x
EV/FCF	101.6x
EV/Sales	7.51x
FCF yield	1%
Forward P/E	16.51x
P/B ratio	39.87x
P/S ratio	7.39x
PS Forward	5.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-10.64%
EBITDA Margin	3%
FCF margin	7.39%
Gross margin	55.95%
Gross Profit	$300M
Gross Profit Growth	751.63%
Gross Profit Growth Q	144.31%
Gross Profit Growth5 Y	90.88%
Net Income	$-21.4M
Net Income Growth Quarters	6%
Net Income Growth Years	1%
Pretax Margin	-8.36%
Profit Margin	-4%
Profit Per Employee	$-43,103
ROA	-6.46
Roa5y	-21.5
ROCE	-13.28
ROE	-69.38
Roe5y	-178.1
ROIC	-40.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.3%
Cagr1y	110.69%
Cagr3y	36.35%
Cagr5y	16.32%
EPS Growth Quarters	6
EPS Growth Years	1
OCF Growth10 Y	31.97%
Revenue Growth	96.03x
Revenue Growth Q	55.63x
Revenue Growth Quarters	11x
Revenue Growth Years	3x
Revenue Growth3 Y	80.05x
Revenue Growth5 Y	22.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.97
Assets	$555.2M
Cash	$264.7M
Current Assets	$392.7M
Current Liabilities	$125.4M
Debt	$327.7M
Debt EBITDA	$15.99
Debt Equity	$3.32
Debt FCF	$8.27
Equity	$98.7M
Interest Coverage	-5.6
Liabilities	$456.5M
Long Term Assets	$162.5M
Long Term Liabilities	$331M
Net Cash	$-63M
Net Cash By Market Cap	$-1.59
Net Debt EBITDA	$3.92
Net Debt Equity	$0.64
Net Debt FCF	$1.59
Tangible Book Value	$-11.3M
Tangible Book Value Per Share	$-0.12
WACC	9.88

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.13
Inventory Turnover	45.92
Net Working Capital	$8.6M
Quick ratio	2.82
Working Capital	$267.2M
Working Capital Turnover	$2.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.28%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	191.58%
1Y total return	110.58%
200-day SMA	29.47
3Y total return	153.57%
50-day SMA	33.67
50-day SMA vs 200-day SMA	50over200
5Y total return	112.89%
All Time High	48.61
All Time High Change	-12.36%
All Time High Date	2026-05-05
All Time Low	2.55
All Time Low Change	1,570.59%
All Time Low Date	2012-12-27
ATR	2.45
Beta	1.14
Beta1y	1.48
Beta2y	1.72
Ch YTD	11.49
High	43.88
High52	48.61
High52 Date	2026-05-05
High52ch	-12.36%
Low	41.77
Low52	13.88
Low52 Date	2025-06-18
Low52ch	206.92%
Ma50ch	26.52%
Premarket Change Percent	0.8
Premarket Price	$43
Premarket Volume	119
Price vs 200-day SMA	44.56%
RSI	62.48
RSI Monthly	70.7
RSI Weekly	67.4
Sharpe ratio	1.3x
Sortino ratio	2.43
Total Return	-10.28%
Tr YTD	11.49
Tr1m	34.51%
Tr1w	-3.45%
Tr3m	43.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	13
Analyst Count Top	6
Analyst Price Target Top	$40.17
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.1
Earnings Revenue Estimate	135,335,328x
Earnings Revenue Estimate Growth	65.58x
Operating Income	$-57.1M
Operating margin	-10.64
Price target	$45.38
Price Target Change	$6.53
Price Target Change Top	$-5.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	91,984,897%
Float Percent	98.92%
Net Borrowing	-68,904,000
Shares Insiders	1.08%
Shares Institutions	113.46%
Shares Out	92,992,905
Shares Qo Q	1.74%
Shares Yo Y	10.28%
Short Float	13.83%
Short Ratio	5.59
Short Shares	13.68

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-9.9M
Average Volume	3,357,691.6x
Bv Per Share	1.07
Ch10y	191.6
Ch1m	34.51
Ch1w	-3.45
Ch1y	110.6
Ch3m	43.39
Ch3y	153.6
Ch5y	112.9
Ch6m	31.73
Change	-0.14%
Change From Open	-1.89
Close	42.66
Days Gap	1.78
Depreciation Amortization	73,153,000
Dollar Volume	96,531,727.8
Earnings Date	2026-05-04
Earnings Time	amc
EBIT	$-57.1M
EBITDA	$16.1M
EPS	$-0.24
F Score	5
FCF	$39.6M
FCF EV Yield	0.98x
FCF Per Share	$0.43
Financing CF	-32,981,000
Fiscal Year End	December
Goodwill	752,000
Income Tax	$829,000
Investing CF	8,151,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-19
Ma150	32.64
Ma150ch	30.53%
Ma20	41.12
Ma20ch	3.61%
Net CF	16,465,000
Next Earnings Date	2026-08-05
Open	43.42
Optionable	Yes
P FCF Ratio	100
P OCF Ratio	100
Position In Range	39.34
Post Close	42.6
Postmarket Change Percent	-1.29
Postmarket Price	$42.05
Ppne	13,295,000
Pre Close	42.66
Price Date	2026-05-08
Price EBITDA	$246
Relative Volume	0.67x
Revenue	536,195,000x
SBC By Revenue	9.24x
Share Based Comp	49,522,000
Tax By Revenue	0.15x
Tr6m	31.73%
Us State	California
Volume	2,266,003
Z Score	0.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TVTX pay a dividend?

Capital-return profile for this ticker.

Performance

TVTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TVTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+113.5%

Float: +98.9% of shares outstanding

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TVTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.5

Neutral momentum band

Price vs 200-day MA

+44.6%

50/200-day relationship not available

Beta (5Y)

1.14

Moves roughly with the market

Sharpe ratio

1.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TVTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TVTX stock rating?

Travere Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TVTX analysis?

The full report lives at /stocks/TVTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TVTX?

The latest report frames TVTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TVTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.